Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Mark Napier"'
Autor:
Ruben Mujica-Mota, Jo Varley-Campbell, Irina Tikhonova, Chris Cooper, Ed Griffin, Marcela Haasova, Jaime Peters, Stefano Lucherini, Juan Talens-Bou, Linda Long, David Sherriff, Mark Napier, John Ramage, Martin Hoyle
Publikováno v:
Health Technology Assessment, Vol 22, Iss 49 (2018)
Background: Neuroendocrine tumours (NETs) are a group of heterogeneous cancers that develop in cells in the diffuse neuroendocrine system. Objectives: To estimate the clinical effectiveness of three interventions [everolimus (Afinitor®; Novartis Int
Externí odkaz:
https://doaj.org/article/ef0ab2f5847e47759e8ad1e5af575ec7
Autor:
Nicola Huxley, Louise Crathorne, Jo Varley-Campbell, Irina Tikhonova, Tristan Snowsill, Simon Briscoe, Jaime Peters, Mary Bond, Mark Napier, Martin Hoyle
Publikováno v:
Health Technology Assessment, Vol 21, Iss 38 (2017)
Background: Colorectal cancer is the fourth most commonly diagnosed cancer in the UK after breast, lung and prostate cancer. People with metastatic disease who are sufficiently fit are usually treated with active chemotherapy as first- or second-line
Externí odkaz:
https://doaj.org/article/b41c56cbf6b34b4f8fbc5d9914b1688d
Autor:
Louise Crathorne, Nicola Huxley, Marcela Haasova, Tristan Snowsill, Tracey Jones-Hughes, Martin Hoyle, Simon Briscoe, Helen Coelho, Linda Long, Antonieta Medina-Lara, Ruben Mujica-Mota, Mark Napier, Chris Hyde
Publikováno v:
Health Technology Assessment, Vol 20, Iss 13 (2016)
Background: Anaemia is a common side effect of cancer treatments and can lead to a reduction in quality of life. Erythropoiesis-stimulating agents (ESAs) are licensed for use in conjunction with red blood cell transfusions to improve cancer treatment
Externí odkaz:
https://doaj.org/article/ac072a1baabe43b897806d575f509e6a
Publikováno v:
Town and Regional Planning, Vol 54, Pp 50-60 (2009)
In 2007 the Presidency called for a review of second economy strategies1 contained within the national housing programme with particular reference to how it has fared in relation to the so-called ‘second economy’. This article draws from that rev
Externí odkaz:
https://doaj.org/article/c5f84ac02bd142cf936712a2b724b261
Autor:
Mark Napier, Stephen Berrisford
Trading Places is about urban land markets in African cities. It explores how local practice, land governance and markets interact to shape the ways that people at society's margins access land to build their livelihoods. The authors argue that the p
Publikováno v:
Quality & Quantity. 56:3875-3891
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78486cd0c322e436119806846178b1c6
https://doi.org/10.1007/s11135-021-01292-7
https://doi.org/10.1007/s11135-021-01292-7
Publikováno v:
Tijdschrift voor economische en sociale geografie. 111:80-98
In line with international trends, South Africa’s post‐apartheid government has embarked on a housing policy that emphasises asset building. Homeownership has become a dominant policy for assisting the historically disadvantaged Black population.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dbc623fab51f1b7328580e9d110fb1c
https://doi.org/10.1111/tesg.12367
https://doi.org/10.1111/tesg.12367
Publikováno v:
The Cochrane Database of Systematic Reviews
Background Despite being preventable, malaria remains an important public health problem. The World Health Organization (WHO) reports that overall progress in malaria control has plateaued for the first time since the turn of the century. Researchers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34333fe19b2e99ea883e52856c6fdf12
https://pubmed.ncbi.nlm.nih.gov/36200610
https://pubmed.ncbi.nlm.nih.gov/36200610
Autor:
Nicola Huxley, Louise Crathorne, Mark Napier, Irina A Tikhonova, Martin Hoyle, Tristan Snowsill, Jo Varley-Campbell
Publikováno v:
PharmacoEconomics. 36:837-851
Combination therapies with cetuximab (Erbitux®; Merck Serono UK Ltd) and panitumumab (Vectibix®; Amgen UK Ltd) are shown to be less effective in adults with metastatic colorectal cancer who have mutations in exons 2, 3 and 4 of KRAS and NRAS oncoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1510fba81ef7db79c2194d0b58dbbf75
https://doi.org/10.1007/s40273-018-0630-9
https://doi.org/10.1007/s40273-018-0630-9